Platelets in ITP: Victims in Charge of Their Own Fate?
Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder. The pathophysiological mechanisms leading to low platelet levels in ITP have not been resolved, but at least involve autoantibody-dependent and/or cytotoxic T cell mediated platelet clearance and impaired megakaryopoiesis. In addition...
Main Authors: | Vivianne S. Nelson, Anne-Tess C. Jolink, Sufia N. Amini, Jaap Jan Zwaginga, Tanja Netelenbos, John W. Semple, Leendert Porcelijn, Masja de Haas, Martin R. Schipperus, Rick Kapur |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/11/3235 |
Similar Items
-
Lifting the fog over ITP
by: Philip Young-Ill Choi
Published: (2020-04-01) -
Potential Diagnostic Approaches for Prediction of Therapeutic Responses in Immune Thrombocytopenia
by: Anne-Tess C. Jolink, et al.
Published: (2021-07-01) -
Novel scientific approaches and future research directions in understanding ITP
by: Sarah M. Hicks, et al.
Published: (2020-04-01) -
Thrombopoietin receptor agonist (TPO-RA) treatment raises platelet counts and reduces anti-platelet antibody levels in mice with immune thrombocytopenia (ITP)
by: Rick Kapur, et al.
Published: (2020-04-01) -
Secondary Immune Thrombocytopenia (ITP) Associated with ChAdOx1 Covid-19 Vaccination – A Case Report
by: Martin Koch, et al.
Published: (2021-07-01)